These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 219934)

  • 21. Iatrogenic causes of neurologic disorders: part 2. Drug-related dysfunctions.
    Buchanan DS
    Geriatrics; 1978 Sep; 33(9):47-52. PubMed ID: 28268
    [No Abstract]   [Full Text] [Related]  

  • 22. [Late neurotoxic damage by organophosphate compounds].
    Lohs K
    Z Arztl Fortbild (Jena); 1984; 78(14):593-6. PubMed ID: 6091351
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of permanent neurological sequelae by lithium intoxication during a thyrotoxicosis (author's transl)].
    Heim J; Pinel JF; Allannic H; Ferrand P; Sabouraud O; Lorcy Y
    Sem Hop; 1981 Sep 8-15; 57(29-32):1349-52. PubMed ID: 6269214
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

  • 25. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient.
    Miller F; Menninger J; Whitcup SM
    J Clin Psychopharmacol; 1986 Jun; 6(3):176-8. PubMed ID: 2872237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms.
    Porter J; Jick H
    Lancet; 1977 Mar; 1(8011):587-8. PubMed ID: 65671
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurological complications of addiction to heroin.
    Richter RW; Pearson J; Bruun B; Challenor YB; Brust JC; Baden MM
    Bull N Y Acad Med; 1973 Jan; 49(1):3-21. PubMed ID: 4344820
    [No Abstract]   [Full Text] [Related]  

  • 28. [The side effects of neuroleptic-therapy].
    Fyrö B
    Lakartidningen; 1972 Mar; 69():89-94. PubMed ID: 4664130
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical detection and assessment of drug induced neurotoxicity.
    Naranjo CA; Fornazzari L; Sellers EM
    Prog Neuropsychopharmacol; 1981; 5(5-6):427-34. PubMed ID: 6280224
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse reactions to neuroleptic drugs.
    Vanĕcek J; Vinar O; Fink Z
    Act Nerv Super (Praha); 1978 Feb; 20(1):50-1. PubMed ID: 147599
    [No Abstract]   [Full Text] [Related]  

  • 31. [Otolaryngologic pathological manifestations due to side effects of drugs].
    Sliwowska W
    Otolaryngol Pol; 1972; 26(6):733-42. PubMed ID: 4144034
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neurologic disorders in acute dichloroethane poisoning].
    Akimov GA; Buchko VM; Kolesnichenko IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(5):687-92. PubMed ID: 665065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine].
    Goldstein B; Lhuillier M
    Ann Med Interne (Paris); 1974; 125(6-7):571-6. PubMed ID: 4374109
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 35. Rare complications in lithium therapy: two case reports.
    Hanus H; Bílý J; Hametová M; Polácková J
    Act Nerv Super (Praha); 1972; 14(2):105. PubMed ID: 5040145
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-induced extrapyramidal syndromes.
    Lader MH
    J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
    [No Abstract]   [Full Text] [Related]  

  • 37. Extrapyramidal syndromes complicating neuroleptic drug therapy.
    Bharucha EP
    J Assoc Physicians India; 1976 Jun; 24(6):383-5. PubMed ID: 1022771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.